?【財華社訊】石四藥集團(02005.HK)公布，集團已取得中國國家藥監(jiān)局有關(guān)復(fù)方電解質(zhì)醋酸鈉葡萄糖注射液(250ml及500ml)和鹽酸甲氧氯普胺注射液(2ml:10mg)的藥品生產(chǎn)注冊批件，均屬于化學藥品第3類，視同通過一致性評價。
特別聲明：以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺“網(wǎng)易號”用戶上傳并發(fā)布，本平臺僅提供信息存儲服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
揚子晚報 2026-04-11 11:33:21
44394 跟貼 44394
香港
